Related Experiment Video
Updated: May 4, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
26.7K
From stool transplants to next-generation microbiota therapeutics
Elaine O Petrof1, Alexander Khoruts2
1Department of Medicine, Division of Infectious Diseases & Gastrointestinal Research Unit; Queens University and Kingston General Hospital, Kingston, ON, Canada.
Gastroenterology
|January 14, 2014
Summary
Fecal microbiota transplantation (FMT) is an effective therapy for Clostridium difficile infection and emerging as a new therapeutic class. Further development requires systematic approaches for broader applications.
Area of Science:
- Microbiology
- Gastroenterology
- Therapeutics Development
Background:
- Clostridium difficile infection (CDI) is a growing epidemic, driving increased use of fecal microbiota transplantation (FMT).
- FMT is highly effective for refractory CDI, highlighting the therapeutic potential of the human microbiota.
- Microbiota imbalance is linked to various diseases, suggesting broader applications for FMT.
Purpose of the Study:
- To discuss the development of microbiota therapeutics as a new class.
- To explore pathways for applying FMT beyond Clostridium difficile indications.
- To emphasize the need for mechanistic understanding and microbial ecology principles in therapeutic development.
Main Methods:
- Review of current practices and future directions in fecal microbiota transplantation.
- Discussion of two distinct development pathways for microbiota therapeutics: whole microbial communities and in vitro-assembled microbial consortia.
- Emphasis on systematic development based on mechanistic understanding and microbial ecology.
Main Results:
- Fecal microbiota transplantation (FMT) is a proven treatment for Clostridium difficile infection.
- The human microbiota is integral to physiology, representing a new class of therapeutics.
- Systematic development is crucial for expanding FMT to non-CDI indications.
Conclusions:
- Fecal microbiota transplantation (FMT) offers a promising therapeutic avenue beyond Clostridium difficile.
- Developing microbiota therapeutics requires a foundation in microbial ecology and mechanistic understanding.
- Two primary development pathways exist: utilizing whole microbial communities or in vitro-assembled specific microorganisms.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
01:22Introduction to the Human Microbiota
209
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
209
01:30Development of Human Microbiota
61
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
01:27Microbiota of the Large Intestine
98
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
98
01:27Microbiota of the Stomach and Small Intestine
77
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
77
01:18Functions of the Gut Microbiota
233
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
233